New findings highlight two decades of evidence supporting pecans in heart-healthy diets
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-May-2026 02:15 ET (30-May-2026 06:15 GMT/UTC)
Bianca Seminotti, PhD is the 2026 recipient of the ACMG Foundation Early Career Travel Award. The ACMG Foundation for Genetic and Genomic Medicine selected Dr. Seminotti based on her abstract “Mitochondrial Function in Fibroblasts from a Patient with Congenital NAD Deficiency due to Biallelic NADSYN1 Variants,” which will be delivered as a platform presentation at the 2026 ACMG Annual Clinical Genetics Meeting.
Chemotherapy saves lives but often leaves patients with nerve damage, causing pain, weakness, and even seizures. Using tiny roundworms as a model, researchers found that sildenafil citrate and a new compound, Resveramorph-3, dramatically reduced nerve problems caused by a common chemotherapy drug. By showing how these drugs protect nerve cells, the study highlights promising strategies to prevent debilitating side effects, helping patients complete treatment and regain control of their bodies.
A new study by Silent Spring Institute identified dozens of hazardous chemicals in hair extensions, including products made from human hair, providing the strongest evidence yet of the potential health risks associated with this largely unregulated category of beauty products that disproportionately affect Black women.
After high-profile water crises like the one in Flint, Michigan, some Americans distrust the safety of tap water, choosing to purchase drinking water from freestanding water vending machines or kiosks. Yet this more expensive water may contain different pollutants than local tap water, according to a study in ACS’ Environmental Science & Technology. Researchers report that water sampled from 20 kiosks in six states sometimes contained lead at levels above public health recommendations.
Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune cells recognize gradually vanish. Researchers at the Technical University of Munich (TUM) have now identified one of the molecular mechanisms behind this process. In an initial study they succeeded in blocking it using an existing cancer drug.